Dan Dong

1.7k total citations
52 papers, 1.2k citations indexed

About

Dan Dong is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Dan Dong has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 12 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Dan Dong's work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (7 papers) and Epigenetics and DNA Methylation (5 papers). Dan Dong is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (7 papers) and Epigenetics and DNA Methylation (5 papers). Dan Dong collaborates with scholars based in China, United States and Australia. Dan Dong's co-authors include Chenghai Zhao, Min Liu, Yu Sun, Wei Wang, Mingli Sun, Guangyan Cai, Xiangmei Chen, Shaoyuan Cui, Yichun Ning and Songbo Xie and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Dan Dong

45 papers receiving 1.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Dan Dong 594 268 160 118 118 52 1.2k
Hui‐Chen Wu 959 1.6× 325 1.2× 139 0.9× 141 1.2× 172 1.5× 42 1.5k
Yan Zhu 365 0.6× 186 0.7× 149 0.9× 119 1.0× 37 0.3× 76 959
Xiyuan Zhang 388 0.7× 115 0.4× 145 0.9× 102 0.9× 68 0.6× 69 1.0k
Chao Sheng 582 1.0× 132 0.5× 172 1.1× 290 2.5× 104 0.9× 64 1.2k
Zhonghui Liu 702 1.2× 174 0.6× 168 1.1× 161 1.4× 77 0.7× 91 1.3k
Elena Gammella 567 1.0× 275 1.0× 190 1.2× 370 3.1× 64 0.5× 33 1.6k
Pasquapina Ciarmela 578 1.0× 105 0.4× 102 0.6× 90 0.8× 107 0.9× 78 2.5k
Jia Chen 501 0.8× 289 1.1× 187 1.2× 76 0.6× 57 0.5× 57 956
Yujing Fang 397 0.7× 236 0.9× 273 1.7× 107 0.9× 72 0.6× 65 996

Countries citing papers authored by Dan Dong

Since Specialization
Citations

This map shows the geographic impact of Dan Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Dong more than expected).

Fields of papers citing papers by Dan Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Dong. The network helps show where Dan Dong may publish in the future.

Co-authorship network of co-authors of Dan Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Dong. A scholar is included among the top collaborators of Dan Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Dong. Dan Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Seong S., Dan Dong, & Zhenning Liu. (2025). Molecular mechanisms in diquat-induced organs injury:insights into cell signaling and potential therapeutic agents. Cell Biology and Toxicology. 41(1). 160–160.
2.
Zhao, Zhiyang, et al.. (2025). UFMylation Modulates OFIP Stability and Centrosomal Localization. Journal of Clinical Laboratory Analysis. 39(6). e70004–e70004.
3.
Sun, Mingli, et al.. (2025). PANoptosis: a potential target of cardiomyopathy. Frontiers in Immunology. 16. 1704465–1704465.
4.
Yuan, Zengrong, Dan Dong, Zhang Li, & Zhonggao Xu. (2025). Telitacicept administration improved immunoglobulin A nephropathy after hematopoietic stem cell transplantation: a case report. Frontiers in Medicine. 12. 1667519–1667519.
5.
Jin, Xin, Dan Dong, Hongmei Yang, et al.. (2024). Ginsenoside Rd reduces cell proliferation of non-small cell lung cancer cells by p53-mitochondrial apoptotic pathway. Heliyon. 10(11). e32483–e32483. 5 indexed citations
6.
Ni, Hua, Miao Chen, Dan Dong, et al.. (2024). CYLD/HDAC6 signaling regulates the interplay between epithelial-mesenchymal transition and ciliary homeostasis during pulmonary fibrosis. Cell Death and Disease. 15(8). 581–581. 6 indexed citations
7.
Dong, Dan, et al.. (2024). SIRT1-FOXOs signaling pathway: A potential target for attenuating cardiomyopathy. Cellular Signalling. 124. 111409–111409.
8.
Liu, Han, et al.. (2024). Molecular understanding and clinical aspects of tumor-associated macrophages in the immunotherapy of renal cell carcinoma. Journal of Experimental & Clinical Cancer Research. 43(1). 242–242. 13 indexed citations
9.
Dong, Dan, et al.. (2023). Dapagliflozin inhibits the activity of lateral habenula to alleviate diabetes mellitus-induced depressive-like behavior. Experimental Neurology. 366. 114448–114448. 12 indexed citations
10.
Dong, Dan, Mingli Sun, Dan Xu, et al.. (2022). Mapping the Hot Spots and Evolution Main Path of Whole-Body Vibration Training Since the 21st Century: A Bibliometric Analysis. Frontiers in Bioengineering and Biotechnology. 10. 920846–920846. 5 indexed citations
11.
Xie, Wei, Mingzhen Chen, Hongjie Li, et al.. (2021). HIV-1 exposure promotes PKG1-mediated phosphorylation and degradation of stathmin to increase epithelial barrier permeability. Journal of Biological Chemistry. 296. 100644–100644. 11 indexed citations
12.
Lei, Na, Zejing Wang, Yu Zuo Bai, et al.. (2021). WNT7B represses epithelial-mesenchymal transition and stem-like properties in bladder urothelial carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868(1). 166271–166271. 15 indexed citations
13.
Sun, Yu, et al.. (2021). EMP3 negatively modulates breast cancer cell DNA replication, DNA damage repair, and stem-like properties. Cell Death and Disease. 12(9). 844–844. 24 indexed citations
14.
Dong, Dan, et al.. (2020). Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma. Frontiers in Oncology. 10. 1566–1566. 6 indexed citations
15.
Shao, Huanjie, Dan Dong, & Fang Shao. (2019). Long non-coding RNA TUG1-mediated down-regulation of KLF4 contributes to metastasis and the epithelial-to-mesenchymal transition of colorectal cancer by miR-153-1. SHILAP Revista de lepidopterología. 2 indexed citations
16.
Yang, Jiao, Jiao Yang, Meng Lv, et al.. (2016). Characteristics of Differently Located Colorectal Cancers Support Proximal and Distal Classification: A Population-Based Study of 57,847 Patients. PLoS ONE. 11(12). e0167540–e0167540. 57 indexed citations
17.
Ning, Yichun, Guangyan Cai, Li Zhuo, et al.. (2014). Beneficial Effects of Short-Term Calorie Restriction against Cisplatin-Induced Acute Renal Injury in Aged Rats. Nephron Experimental Nephrology. 124(3-4). 19–27. 42 indexed citations
18.
Dong, Dan, et al.. (2012). Advances and prospects of anginex as a promising anti-angiogenesis and anti-tumor agent. Peptides. 38(2). 457–462. 19 indexed citations
19.
Gao, Jianjun, Guangyan Cai, Yichun Ning, et al.. (2012). DAP5 Ameliorates Cisplatin-Induced Apoptosis of Renal Tubular Cells. American Journal of Nephrology. 35(5). 456–465. 14 indexed citations
20.
Liu, Xiaoyan, et al.. (2009). Expression and location of α-fetoprotein during rat colon development. World Journal of Gastroenterology. 15(14). 1738–1738. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026